Transmembrane serine protease overexpressed in ovarian...

Details Transmembrane serine protease overexpressed in ovarian... Transmembrane serine protease overexpressed in ovarian...

2006-04-07

2009-12-29

Goddard, Laura B (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

07638277

ABSTRACT:
The present invention provides a TADG-12 protein and a DNA fragment encoding such protein. Also provided is a vector/host cell capable of expressing the DNA. The present invention further provides various methods of early detection of associated ovarian and other malignancies, and of interactive therapies for cancer treatment by utilizing the DNA and/or protein disclosed herein.

REFERENCES:
patent: 6294663 (2001-09-01), O'Brien et al.
patent: 6303318 (2001-10-01), O'Brien
Sawasaki et al (Tumor Biology, 2004, 25:141-148).
Wallrapp et al (Cancer Research, 2000, 60:2602-2606).
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
Underwood et al (Biochemica et Biophysica Acta, 2000, 1502:337-350).

Affiliated with

Also associated with

Rating

Transmembrane serine protease overexpressed in ovarian... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transmembrane serine protease overexpressed in ovarian..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transmembrane serine protease overexpressed in ovarian... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4116092